{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:22:07Z","timestamp":1790702527065,"version":"4.1.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Cerenis Therapeutics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s40261-017-0506-3","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T15:08:57Z","timestamp":1487344137000},"page":"483-491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Development of CER-001: Preclinical Dose Selection Through to Phase I Clinical Findings"],"prefix":"10.1007","volume":"37","author":[{"given":"Constance H.","family":"Keyserling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Barbaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Benghozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Dasseux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"506_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0009-3084(96)02535-2","volume":"81","author":"P Mattjus","year":"1996","unstructured":"Mattjus P, Slotte JP. Does cholesterol discriminate between sphingomyelin and phosphatidylcholine in mixed monolayers containing both phospholipids? Chem Phys Lipids. 1996;81:69\u201380.","journal-title":"Chem Phys Lipids"},{"key":"506_CR2","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S0006-3495(99)77254-1","volume":"76","author":"B Ramstedt","year":"1999","unstructured":"Ramstedt B, Slotte JP. Interaction of cholesterol with sphingomyelins and acyl-chain-matched phosphatidylcholines: a comparative study of the effect of the chain length. Biophys J. 1999;76:908\u201315.","journal-title":"Biophys J"},{"key":"506_CR3","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1172\/JCI116831","volume":"92","author":"A Guasch","year":"1993","unstructured":"Guasch A, Deen WM, Myers BD. Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans. J Clin Invest. 1993;92:2274\u201382.","journal-title":"J Clin Invest."},{"key":"506_CR4","doi-asserted-by":"publisher","first-page":"16221","DOI":"10.1074\/jbc.270.27.16221","volume":"270","author":"A Rigotti","year":"1995","unstructured":"Rigotti A, Acton SL, Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem. 1995;270:16221\u20134.","journal-title":"J Biol Chem"},{"key":"506_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2013.10.018","volume":"232","author":"C Tardy","year":"2014","unstructured":"Tardy C, Goffinet M, Boubekeur N, et al. CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice. Atherosclerosis. 2014;232:110\u20138.","journal-title":"Atherosclerosis."},{"key":"506_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2016.05.038","volume":"251","author":"KH Zheng","year":"2016","unstructured":"Zheng KH, van der Valk FM, Smits LP, et al. Recombinant human apolipoprotein A-I HDL CER-001 targets plaques in patients with atherosclerotic disease: the LOCATION study. Atherosclerosis. 2016;251:381\u20138.","journal-title":"Atherosclerosis."},{"key":"506_CR7","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1093\/eurheartj\/ehu171","volume":"35","author":"JC Tardif","year":"2014","unstructured":"Tardif JC, Ballantyne CM, Barter P, et al. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial. Eur Heart J. 2014;35:3277\u201386.","journal-title":"Eur Heart J"},{"issue":"3","key":"506_CR8","first-page":"6","volume":"132","author":"Y Kataoka","year":"2015","unstructured":"Kataoka Y, Andrews J, Duong M, et al. Greater regression of coronary atherosclerosis with the pre-beta high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burden. Circulation. 2015;132(Suppl_3):A12156.","journal-title":"Circulation."},{"issue":"736\u201342","key":"506_CR9","first-page":"e1","volume":"169","author":"GK Hovingh","year":"2015","unstructured":"Hovingh GK, Smits LP, Stefanutti C, et al. The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: the Modifying Orphan Disease Evaluation (MODE) study. Am Heart J. 2015;169(736\u201342):e1.","journal-title":"Am Heart J"},{"key":"506_CR10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1194\/jlr.M055665","volume":"56","author":"RS Kootte","year":"2015","unstructured":"Kootte RS, Smits LP, van der Valk FM, et al. Effect of open-label infusion of an apolipoprotein A-I-containing particle (CER-001) on reverse cholesterol transport and artery wall thickness in patients with familial hypo-alphalipoproteinemia. J Lipid Res. 2015;56:703\u201312.","journal-title":"J Lipid Res"},{"key":"506_CR11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-2275(20)30123-1","volume":"43","author":"S Usui","year":"2002","unstructured":"Usui S, Hara Y, Hosaki S, Okazaki M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res. 2002;43:805\u201314.","journal-title":"J Lipid Res"},{"key":"506_CR12","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","volume":"290","author":"SE Nissen","year":"2003","unstructured":"Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA. 2003;290:2292\u2013300.","journal-title":"JAMA"},{"issue":"9","key":"506_CR13","doi-asserted-by":"publisher","first-page":"e0137584","DOI":"10.1371\/journal.pone.0137584","volume":"10","author":"C Tardy","year":"2015","unstructured":"Tardy C, Goffinet M, Boubekeur N, et al. HDL and CER-001 inverse-dose dependent inhibition of atherosclerotic plaque formation in apoE\u2212\/\u2212 mice: Evidence of ABCA1 down-regulation. PLoS One. 2015;10(9):e0137584.","journal-title":"PLoS One"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0506-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-017-0506-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0506-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T11:05:14Z","timestamp":1658660714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-017-0506-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["506"],"URL":"https:\/\/doi.org\/10.1007\/s40261-017-0506-3","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]}}}